GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season.
Fluarix® Tetra is a four-strain flu vaccine indicated for the active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the influenza virus types A and B contained in the vaccine.
Most flu vaccines today contain three strains of flu. Four-strain flu vaccines include an additional B strain of influenza.
“The vaccine contains inactivated A and B virus strains, which can help reduce the likelihood of catching any of four different strains of seasonal flu.”